Pterostilbene alleviates pulmonary fibrosis by regulating ASIC2

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a serious chronic disease of the respiratory system, but its current treatment has certain shortcomings and adverse effects. In this study, we evaluate the antifibrotic activity of pterostilbene (PTE) using an in vitro IPF model induced by transform...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yanfang, Zhang, Yingwen, Zhang, Yabing, Wang, Xiuping, Xia, Yukun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317282/
https://www.ncbi.nlm.nih.gov/pubmed/34321072
http://dx.doi.org/10.1186/s13020-021-00474-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317282/
https://www.ncbi.nlm.nih.gov/pubmed/34321072
http://dx.doi.org/10.1186/s13020-021-00474-7

Ejemplares similares